DC 6817STRONG evidenceLast verified: MAR 11, 2026

Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease (COPD) / Emphysema

Pulmonary Hypertension can develop as a service-connected secondary condition to Chronic Obstructive Pulmonary Disease (COPD) / Emphysema when a medical nexus links the two under 38 CFR § 3.310. The strength of medical evidence for this specific pairing is strong. Pulmonary hypertension (PH) is a direct anatomical complication of COPD that develops through progressive destruction of the pulmonary vascular bed.

How is Pulmonary Hypertension connected to Chronic Obstructive Pulmonary Disease (COPD) / Emphysema?

Pulmonary hypertension (PH) is a direct anatomical complication of COPD that develops through progressive destruction of the pulmonary vascular bed. In COPD, emphysematous alveolar destruction obliterates alveolar capillaries, mechanically reducing the cross-sectional area of the pulmonary vascular bed and increasing pulmonary vascular resistance. Chronic alveolar hypoxia triggers sustained hypoxic pulmonary vasoconstriction (HPV) in remaining vessels via Rho-kinase pathway activation, causing pulmonary arteriolar smooth muscle hypertrophy and remodeling. Endothelial dysfunction from oxidative stress further impairs vasodilation. Cor pulmonale (right heart failure from pulmonary hypertension) is the terminal cardiac complication of COPD. COPD is the most common cause of PH (Group 3 pulmonary hypertension) worldwide.

“Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected.”
— 38 CFR § 3.310(a), Disabilities that are proximately due to, or aggravated by, service-connected disease or injury

What evidence supports claiming Pulmonary Hypertension as secondary to Chronic Obstructive Pulmonary Disease (COPD) / Emphysema?

Chaouat A et al. (2008) Eur Respir J (PH in COPD); Barbera JA et al. (2003) Eur Respir J (mechanisms of PH in COPD); Weitzenblum E & Chaouat A (2009) Eur Respir Rev; Seeger W et al. (2013) J Am Coll Cardiol (PH classification and COPD).

How do I file a secondary claim for Pulmonary Hypertension?

Right heart catheterization (definitive diagnosis, mean PAP > 25 mmHg) or echocardiography documenting elevated right ventricular systolic pressure (RVSP > 40 mmHg) and right heart enlargement. Pulmonology records documenting COPD as the primary etiology. A nexus letter from your pulmonologist specifically attributing PH to COPD-related alveolar destruction and hypoxic vasoconstriction. PH rated under DC 6817 as part of the cardiac involvement — right heart failure and cor pulmonale significantly increase the combined disability rating.

How does the VA rate Pulmonary Hypertension?

Pulmonary Hypertension is rated under 38 CFR Part 4 using the diagnostic code assigned to that condition. The VA evaluates the severity of the secondary condition independently and assigns a rating from 0% to 100% in increments defined in the rating schedule. That rating is then combined with Chronic Obstructive Pulmonary Disease (COPD) / Emphysema and all other service-connected conditions using the combined ratings formula under § 4.25.

Pulmonary Hypertension is rated under DC 6817 in 38 CFR Part 4.

Common Questions — Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease (COPD) / Emphysema

Can Pulmonary Hypertension be claimed as secondary to Chronic Obstructive Pulmonary Disease (COPD) / Emphysema?

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Pulmonary Hypertension is a documented secondary pairing for Chronic Obstructive Pulmonary Disease (COPD) / Emphysema with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

What evidence proves Pulmonary Hypertension is caused by Chronic Obstructive Pulmonary Disease (COPD) / Emphysema?

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

Does the VA combine or separately rate Pulmonary Hypertension?

The VA rates Pulmonary Hypertension separately under its own 38 CFR Part 4 diagnostic code, then combines it with Chronic Obstructive Pulmonary Disease (COPD) / Emphysema and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

What legal standard applies to secondary service connection?

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

How strong is the medical evidence for this pairing?

The medical evidence supporting Pulmonary Hypertension as secondary to Chronic Obstructive Pulmonary Disease (COPD) / Emphysema is rated strong. Pulmonary hypertension (PH) is a direct anatomical complication of COPD that develops through progressive destruction of the pulmonary vascular bed. In COPD, emphysematous alveolar destruction obliterates alveolar capillaries, mechanically reducing the cross-sectional area of the pulmonary vascular bed and increasing pulmonary vascular resistance. Chronic alveolar hypoxia triggers sustained hypoxic pulmonary vasoconstriction (HPV) in remaining vessels via Rho-kinase pathway activation, causing pulmonary arteriolar smooth muscle hypertrophy and remodeling. Endothelial dysfunction from oxidative stress further impairs vasodilation. Cor pulmonale (right heart failure from pulmonary hypertension) is the terminal cardiac complication of COPD. COPD is the most common cause of PH (Group 3 pulmonary hypertension) worldwide.

Do I need a nexus letter for a secondary claim?

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.

Get a Full Secondary Condition Analysis

VeteranHQ cross-references your complete medical history against the full secondary condition database, surfacing every secondary claim opportunity for your specific service-connected conditions.

Start Your Free Analysis